v3.26.3
Other Non-Marketable Equity Securities
9 Months Ended
Sep. 30, 2026
Other Non-Marketable Equity Securities [Abstract]  
OTHER NON-MARKETABLE EQUITY SECURITIES

NOTE 10 – OTHER NON-MARKETABLE EQUITY SECURITIES:

 

    September 30,
2026
    December 31,
2025
 
Diasome   $ 3,524     $ 3,524  
Hopec Pharma Ltd. (1)     500       -  
Other     400       100  
    $ 4,424     $ 3,624  

 

  (1) Hopec Pharma Ltd.

 

In May 2026, the Company entered into a Simple Agreement for Future Equity (the “SAFE”) with Hopec Pharma Ltd. (“Hopec”), pursuant to which the Company agreed to invest up to $1,000 in Hopec. The Company invested $500 upon entering into the SAFE and, at the Company’s discretion, may invest an additional $500 following receipt of written notice of the successful results from the Week 14 cystoscopy assessment of the third patient in the first cohort of Hopec’s clinical study.